Evenity Market Report 2026

Evenity Market Overview

• The Evenity market growth in the historic period has been driven by aging female population, high prevalence of postmenopausal osteoporosis • Market expansion is supported by growing awareness of bone health, increasing osteoporosis screening • Growth Driver: Rising Osteoporosis Prevalence To Drive Growth Of Market • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Evenity Market?

Evenity (romosozumab) is a biologic medication used to treat osteoporosis in postmenopausal women at high risk of fractures by inhibiting sclerostin, promoting bone growth, and reducing bone loss. Administered through monthly subcutaneous injections, it is typically used for up to 12 months, after which other treatments may be recommended. The main types of indications in evenity are postmenopausal osteoporosis and osteoporosis in men. Postmenopausal osteoporosis is bone loss due to reduced estrogen after menopause, treated with medications like bisphosphonates and romosozumab. It is distributed through hospital pharmacies, retail pharmacies, and online pharmacies and caters to various end users, including hospitals and clinics, specialty centers, homecare settings, research, and academic institutions.

What Is The Evenity Market Growth Forecast?

The growth in the forecast period can be attributed to growing awareness of bone health, increasing osteoporosis screening, expanding use of biologics, rising healthcare access for elderly populations, supportive reimbursement for fracture prevention. Major trends in the forecast period include rising use of anabolic osteoporosis therapies, growing focus on fracture risk reduction, preference for monthly injectable treatments, short duration high efficacy osteoporosis regimens, integration of biologic therapies in bone health.

What Are The Drivers Of The Evenity Market?

The increasing prevalence of osteoporosis is expected to propel the growth of the evenity market going forward. Osteoporosis is a medical condition characterized by a decrease in bone density and quality, leading to weakened bones that are more prone to fractures. The rising prevalence of osteoporosis is driven by an aging population with naturally decreasing bone density and sedentary lifestyles that weaken skeletal strength. Evenity is administered as a monthly injection for up to 12 months to treat osteoporosis by increasing bone formation, reducing bone resorption, and strengthening bones to prevent fractures. For instance, in February 2023, the Royal Osteoporosis Society, a UK based charity, submitted written evidence estimating that fragility fractures cost the NHS $5.89billion (£4.5 billion) per year, with hip fractures alone accounting for $2.62 billion (£2 billion) of that cost. Therefore, the increasing prevalence of osteoporosis is driving the growth of the evenity industry. The increasing number of drug approvals is expected to drive the growth of the evenity market in the coming years. Drug approvals involve the formal evaluation and authorization of pharmaceutical drugs by regulatory authorities for public use. This rise in approvals is primarily due to advancements in biotechnology, which facilitate faster drug discovery, and supportive regulatory frameworks, such as accelerated approval programs, that streamline the process for high-demand medications. Drug approvals contribute to evenity growth by increasing the availability of innovative treatment options, enhancing patient accessibility, and fostering confidence among healthcare providers. For instance, in July 2024, according to the American Society of Gene and Cell Therapy (ASGCT), a US-based professional membership organization, in the second quarter of 2024, 76 gene therapy trials were initiated, marking a 25% increase compared to the previous quarter. Therefore, increasing the number of drug approvals is driving the growth of the evenity industry. The increasing healthcare expenditure is anticipated to drive the growth of the evenity market in the future. Healthcare expenditure represents the total financial resources allocated to medical services, preventive care, medications, and health-related activities aimed at enhancing or maintaining population health. This expenditure is rising due to the aging population's greater demand for medical care and technological advancements that contribute to higher treatment costs. Healthcare expenditure for Evenity is allocated to cover medication costs, enhance healthcare infrastructure, and improve access to osteoporosis treatments, particularly for aging populations. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the rising healthcare expenditure is driving the growth of the evenity industry.

Key Players In The Global Evenity Market

Major companies operating in the evenity market are Amgen Inc., UCB S.A

What Defines the Evenity Market?

The evenity market consists of sales of products including evenity injection, evenity autoinjectors, and evenity pre-filled syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Evenity Market Report 2026?

The evenity market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the evenity industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.